REQUEST A DEMO
Total
USD $0.00
Search more companies

Biohem, spol. s r.o. (Slovakia)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Biohem, spol. s r.o. Profile Updated: December 17, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

BIOHEM spol. s r.o. was established in 1993 and today is a distributor of pharmaceuticals and medical devices in Slovakia. BIOHEM is a direct importer of wide range of pharmaceutical products, medical devices, laboratory diagnostics and medical instruments and has contracts with multinational manufacturers such as BAXTER, Dade Behring, Dia Med, bioMerieux or Miltenyi Biotec. End of 2005 BIOHEM was awarded the ISO 9001:2000 Certificate for quality management, distribution and service. Since 2005 has been a part of the multinational corporation GROVE GROUP.

Headquarters
Zlatovska 2211
Trencin; Trenciansky; Postal Code: 91105

Contact Details: Purchase the Biohem, spol. s r.o. report to view the information.

Basic Information
Total Employees:
Purchase the Biohem, spol. s r.o. report to view the information.
Outstanding Shares:
Purchase the Biohem, spol. s r.o. report to view the information.
Registered Capital:
Purchase the Biohem, spol. s r.o. report to view the information.
Incorporation Date:
September 30, 1993
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Biohem, spol. s r.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-0.73%
Total operating revenue
3.52%
Operating profit (EBIT)
-16.94%
EBITDA
-14.5%
Net Profit (Loss) for the Period
-17.09%
Total assets
13.56%
Total equity
40.82%
Operating Profit Margin (ROS)
-2.42%
Net Profit Margin
-1.88%
Return on Equity (ROE)
-22%
Debt to Equity Ratio
97.66%
Quick Ratio
0.11%
Cash Ratio
-0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?